These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11693822)

  • 21. Multiple endocrine neoplasia type 2A with the identical somatic mutation in medullary thyroid carcinoma and pheochromocytoma without germline mutation at the corresponding site in the RET proto-oncogene.
    Akama H; Noshiro T; Kimura N; Shimizu K; Watanabe T; Shibukawa S; Nakai S; Miura W; Ito S; Miura Y
    Intern Med; 1999 Feb; 38(2):145-9. PubMed ID: 10225670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference between familial and sporadic medullary thyroid carcinomas.
    Mears L; Diaz-Cano SJ
    Am J Surg Pathol; 2003 Feb; 27(2):266-7. PubMed ID: 12548176
    [No Abstract]   [Full Text] [Related]  

  • 23. RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.
    Orlandi F; Chiefari E; Caraci P; Mussa A; Gonzatto I; De Giuli P; Giuffrida D; Angeli A; Filetti S
    J Endocrinol Invest; 2001 Jan; 24(1):51-5. PubMed ID: 11227733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
    Sanso GE; Domene HM; Garcia R; Pusiol E; de M; Roque M; Ring A; Perinetti H; Elsner B; Iorcansky S; Barontini M
    Cancer; 2002 Jan; 94(2):323-30. PubMed ID: 11900218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid carcinoma: diagnostic and therapeutic approach; genetic background (review).
    Lewinski A; Ferenc T; Sporny S; Jarzab B
    Endocr Regul; 2000 Jun; 34(2):99-113. PubMed ID: 10991553
    [No Abstract]   [Full Text] [Related]  

  • 26. Genetics. One gene--four syndromes.
    van Heyningen V
    Nature; 1994 Jan; 367(6461):319-20. PubMed ID: 7906865
    [No Abstract]   [Full Text] [Related]  

  • 27. Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
    Marsh DJ; Andrew SD; Learoyd DL; Pojer R; Eng C; Robinson BG
    Hum Mutat; 1998; Suppl 1():S3-4. PubMed ID: 9452023
    [No Abstract]   [Full Text] [Related]  

  • 28. Medullary thyroid carcinoma and lack of renal agenesis.
    Lombardo F; Filetti S; Crocetti U; Schlumberger M
    Thyroid; 2001 Jan; 11(1):93. PubMed ID: 11272104
    [No Abstract]   [Full Text] [Related]  

  • 29. [Ret proto-oncogene mutation found in the Czech population and its predictive value for offspring of patients with medullary carcinoma of the thyroid gland].
    Mazura I; Vcelák J; Bendlová B; Neradilová M; Nĕmec J; Stolba P
    Vnitr Lek; 1996 Nov; 42(11):751-6. PubMed ID: 9012117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel germline RET proto-oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC.
    Kitamura Y; Goodfellow PJ; Shimizu K; Nagahama M; Ito K; Kitagawa W; Akasu H; Takami H; Tanaka S; Wells SA
    Oncogene; 1997 Jun; 14(25):3103-6. PubMed ID: 9223675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years.
    Demeester R; Parma J; Cochaux P; Vassart G; Abramowicz MJ
    Hum Mutat; 2001 Apr; 17(4):354. PubMed ID: 11295841
    [No Abstract]   [Full Text] [Related]  

  • 32. [Diagnosis and therapy of medullary thyroid carcinoma].
    Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
    Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation.
    Michiels FM; Chappuis S; Caillou B; Pasini A; Talbot M; Monier R; Lenoir GM; Feunteun J; Billaud M
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3330-5. PubMed ID: 9096393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients.
    Wiench M; Wygoda Z; Gubala E; Wloch J; Lisowska K; Krassowski J; Scieglinska D; Fiszer-Kierzkowska A; Lange D; Kula D; Zeman M; Roskosz J; Kukulska A; Krawczyk Z; Jarzab B
    J Clin Oncol; 2001 Mar; 19(5):1374-80. PubMed ID: 11230481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A primary, lateral-cervical medullary thyroid carcinoma: a case report.
    Santini L; Scurini C; Caracò C; Conzo G; Orabona P; De Rosa G; Fattoruso O; Colantuoni V
    J Clin Endocrinol Metab; 1996 May; 81(5):1784-6. PubMed ID: 8626835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prophylactic total thyroidectomy in children and adolescents with genetic mutations in the RET-protooncogene].
    Spinelli C; Puccini M; Bertocchini A; Lima M; Pacini F; Miccoli P
    Pediatr Med Chir; 2002; 24(1):53-7. PubMed ID: 11938683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RET proto-oncogene mutations and rearrangements in endocrine diseases.
    Lloyd RV
    Am J Pathol; 1995 Dec; 147(6):1539-44. PubMed ID: 7495277
    [No Abstract]   [Full Text] [Related]  

  • 38. Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations.
    Miyauchi A; Matsuzuka F; Hirai K; Yokozawa T; Kobayashi K; Ito Y; Nakano K; Kuma K; Futami H; Yamaguchi K
    World J Surg; 2002 Aug; 26(8):1023-8. PubMed ID: 12016484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathology forum: quiz case 1. Early medullary thyroid carcinoma (MTC), familial type, arising in a background of C-cell hyperplasia.
    Parwani AV; Allan RW; Westra WH; Udelsman R; Ball DW; Argani P
    Arch Otolaryngol Head Neck Surg; 2001 May; 127(5):594, 596-7. PubMed ID: 11346440
    [No Abstract]   [Full Text] [Related]  

  • 40. The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.
    Melillo RM; Cirafici AM; De Falco V; Bellantoni M; Chiappetta G; Fusco A; Carlomagno F; Picascia A; Tramontano D; Tallini G; Santoro M
    Am J Pathol; 2004 Aug; 165(2):511-21. PubMed ID: 15277225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.